Brief: Avenue Therapeutics ReceiveS Appeal Denied Letter From FDA In Response To Its Formal Dispute Resolution Request Submitted In Aug 2021

Avenue Therapeutics

21/03/2022 13:41

March 21 (Reuters) - Avenue Therapeutics Inc  ATXI.O :
    * AVENUE THERAPEUTICS- ON MARCH 18, CO RECEIVED APPEAL
DENIED
LETTER FROM FDA IN RESPONSE TO ITS FORMAL DISPUTE RESOLUTION
REQUEST SUBMITTED IN AUG 2021
    * AVENUE THERAPEUTICS - EVALUATING NEXT STEPS WITH REGARD TO
IV
TRAMADOL

Further company coverage:  ATXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))